Purpose: To disclose, using an ex vivo study, the histopathological mechanism behind in vivo thickening of the endothelium/ Descemet membrane complex (En/DM) observed in rejected corneal grafts (RCGs).
D
espite the cornea's immune-privileged status, 29% of corneal transplants performed by penetrating keratoplasty fail due to rejection. 1, 2 Respectively, grafts with at least one rejection episode had an almost 3 years shorter mean survival than those with none. 1 An immunological reaction against the donor's endothelial cell layer is responsible for most of these episodes (endothelial rejection). Destruction of these nonregenerating cells results in corneal edema and graft failure. Therefore, identifying rejection episodes is paramount to promptly treat them and prolong graft survival. 2 Unfortunately, no gold standard exists to monitor and reliably diagnose rejection episodes in follow-up.
Tissue basement membrane thickening has been established as evidence of graft rejection in renal, hepatic, and lung grafts. Likewise, this thickening has been suggested to predict graft survival and immunological status. [3] [4] [5] [6] [7] Evaluating the basement membrane in other organ transplants requires invasive biopsies but corneal transplants are transparent and allow for noninvasive evaluation through ocular imaging modalities. It has been demonstrated in the past that high-definition optical coherence tomography (HD-OCT) can measure the endothelium/Descemet membrane complex (En/DM) thickness in vivo. [8] [9] [10] Our previous work showed that thickening of the En/DM occurs in corneal grafts undergoing rejection similarly to other rejected organ transplants. We also demonstrated that En/DM thickness can possibly serve as a diagnostic index for graft rejection with better sensitivity, specificity, and accuracy than the central corneal thickness (CCT). 11 However, this study was restricted by the resolution of HD-OCT that was unable to differentiate the En/DM's individual layers [endothelium, Descemet membrane (DM), and the retrocorneal membrane, if present]. Therefore, we were not able to identify the source of thickening.
The aim of this study was to address this limitation and assess a new factor of corneal graft rejection. We conducted a retrospective histopathological ex vivo study that further examined the individual layers of the En/DM under light microscopy to disclose the histopathological mechanism behind the changes observed on HD-OCT.
METHODS

Study Population
For this retrospective study, initially 77 patients with rejected corneal grafts (RCGs) that underwent replacement surgery were identified by chart review from the years 2013 to 2015. Similarly, over 200 control samples were identified by review of the Florida Lions Ocular Pathology Laboratory database at the Bascom Palmer Eye Institute from 1998 to 2015. Controls were globes with choroidal melanoma posterior to the lens without corneal or angle involvement. All samples were paraffin sections (4 mm in thickness) of the corneal tissues obtained from the Florida Lions Ocular Pathology Laboratory and assessed for histological characteristics. All slides had been prepared with hematoxylin, eosin, and periodic acid-Schiff base stains within 24 hours of surgical removal after formalin fixing with paraffin embedding. Control corneas that were determined not to be clear and unremarkable were also excluded (presence of guttae, poor PAS staining, obvious stromal infiltration, and/or any other abnormal findings). For both groups, samples that were unmeasurable because of degradation, tissue folding, or other reasons were removed from the study. This resulted in 31 RCGs (13 males and 18 females) and 23 control samples (15 males and 8 females). The University of Miami institutional review board approved the pathology review.
Ex Vivo Histopathological Study
Three thickness measurements at the center of each corneal specimen were obtained that included the CCT, central DM thickness, and if present the central endothelium and retrocorneal membrane. Measurements were performed using an Olympus BH-2 light microscope (Olympus Optical Co, Tokyo, Japan) with an eyepiece reticle calibrated to measure 2.25, 4.50, and 9.00 mm increments at 400·, 200·, and 100· magnification.
Statistical Analysis
SPSS software version 22.0 (SPSS, Chicago, IL) was used for statistical analysis using a 2-sided Student t-test with P , 0.05 considered statistically significant. Values are presented as mean 6 SD.
RESULTS
The ex vivo study disclosed a significant difference between the central DM thickness (6.53 6 2.35 mm) in RCGs compared with the controls (3.91 6 1.54 mm, P , 0.001, Fig. 1 ). There was no significant difference in the ex vivo CCT between the 2 groups as shown in Table 1 (P = 0.147). On chart review, 27 of the 31 patients had confirmed graft failure secondary to endothelial rejection. The remaining 4 had presumed rejection based on the patients' clinical history. Eleven patients had glaucoma and 17 did not. DM thickness was not significantly different between these 2 subgroups (P = 0.712). Presence or absence of glaucoma was unknown for 3 patients.
There was no significant difference between the ages of the RCGs and controls (P = 0.314). Corneal age in the control group was the age of the patient at the time the eye was surgically removed. Nevertheless, in the RCG group, the corneal age of the graft was calculated as the sum of the age of the donor and the time from grafting surgery until the time of resection of the graft and submitting it to histopathological evaluation. The average time from initial grafting surgery to resection (regrafting) was 8.0 6 12.0 years. This information was not available for 4 specimens of the RCG group. The average time between the onset of rejection and corneal transplant replacement surgery was 10.4 6 12.3 months. This information was not available for 9 specimens of the RCG group. All control specimens had endothelium but each rejected graft lacked it (Fig. 1) . A central retrocorneal membrane was observed in only 3 RCG specimens and in none of the control specimens.
DISCUSSION
In our previous in vivo investigation, we established the total endothelial/Descemet membrane complex (En/DM) thickness measured in vivo by HD-OCT as a diagnostic index for corneal graft rejection. It was a more accurate, sensitive, and specific index of rejection than CCT both in actively rejecting and RCGs. 11 We also compared the En/DM thickness relative to the thickening of the entire cornea in actively rejecting grafts. This ratio was greater than one, which suggests that there was intrinsic thickening within the En/DM layers. The ratio was even greater in RCG.11 En/DM thickening may have resulted from deposition of metabolic and/or immune end products as a graft undergoes rejection. 11 En/DM thickening may have resulted from deposition of metabolic and/or immune end products as a graft undergoes rejection. Unfortunately, we were unable to differentiate the components of the En/DM and identify the source of thickening. This initiated us to conduct this ex vivo histopathological study to investigate the histological changes of the En/DM in RCGs.
Of the 3 layers, corneal endothelial cells produce the posterior amorphous region of their basement membrane analogous to that of other body organs to form DM. 12 Thickened laminated DM along with the presence of retrocorneal membranes has been observed in RCGs previously under light microscopy. 13 Our previous investigation actually observed a fibrous retrocorneal membrane in 4 of 9 rejected grafts when examined ex vivo. 11 As a result of this ex vivo study, we put forth data here to establish DM as the source of thickening of the En/DM in RCGs. We also demonstrate the unreliability of the CCT that was not significantly different in RCGs compared with controls. Much of the CCT thickening observed is caused by edema that likely had been removed by the alcohol dehydration process during preparation of the histopathological slides. Interestingly, this did not seem to be the case with DM indicating that an underlying immune process may be occurring. Future directions should examine the pathogenic mechanism behind the thickening of DM.
Our ex vivo study has its limitations, including a small sample size. We assumed that 4 of the RCGs with an unknown history failed due rejection but may have had tissue failure unrelated to rejection. With respect to the control group, grafts that have undergone full-thickness penetrating keratoplasty without a history of rejection episodes would have been ideal. Cadavers are the only source of these samples and are therefore very difficult to obtain. Another comparison could have been corneal removal in controls immediately after the whole eye had been enucleated. Although the storage media were the same, the RCG group and control group were slightly different (cornea only vs. whole globe). An artifact in either may have induced tissue thickening.
This study was not conducted on the same eyes included in the past in vivo study or on actively rejecting corneal grafts. 11 Neither study correlated the En/DM or Descemet thickening with the rejection duration or clinically determined severity of graft rejection. To address these limitations, future longitudinal research should look at a single study group (from the day of transplantation to complete rejection) and study the histopathology of the same in vivo eyes after excision for regrafting or a subject's expiration. This ex vivo study has disclosed that thickening of the En/DM measured in vivo by HD-OCT is due to DM and not the endothelium or retrocorneal membrane. Knowing the source of thickening improves the understanding of the pathogenesis of graft rejection and the mechanism behind in vivo observations. This may have the potential to disclose new pathways of graft rejections and thus new treatment modalities. Data presented as mean 6 SD (range). Corneal age in the control group was the age of the patient at the time the eye was surgically removed. Nevertheless, in the rejected graft group, corneal age of the graft was calculated as the sum of the age of the donor and the time from grafting surgery until the time of resection of the graft and submitting it to histopathological evaluation. This information was absent in 4 specimens in the RCG group.
DMT, central Descemet membrane thickness.
